Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Non-cash Items: 2017

Historic Non-cash Items for Summit Therapeutics (SMMT) over the last 1 years, with Oct 2017 value amounting to $362.9 billion.

  • Summit Therapeutics' Non-cash Items was N/A to $362.9 billion in Q4 2017 from the same period last year, while for Oct 2017 it was $362.9 billion, marking a year-over-year change of. This contributed to the annual value of $9.9 million for FY2017, which is N/A change from last year.
  • According to the latest figures from Q4 2017, Summit Therapeutics' Non-cash Items is $362.9 billion, which was up 105.28% from $176.8 billion recorded in Q3 2017.
  • Over the past 5 years, Summit Therapeutics' Non-cash Items peaked at $10,614.8 billion during Q2 2017, and registered a low of $1.60 during Q1 2017.
  • For the 1-year period, Summit Therapeutics' Non-cash Items averaged around $2,788.6 billion, with its median value being $269.8 billion (2017).